Literature DB >> 13627989

Surgical treatment of hyperparathyroidism.

F GLENN.   

Abstract

Entities:  

Keywords:  PARATHYROID GLANDS/diseases

Mesh:

Year:  1959        PMID: 13627989      PMCID: PMC1450996          DOI: 10.1097/00000658-195903000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  8 in total

1.  Changing diagnostic criteria for hyperparathyroidism.

Authors:  L GOLDMAN; G S GORDAN; E L CHAMBERS
Journal:  Ann Surg       Date:  1957-09       Impact factor: 12.969

2.  Tumors of the parathyroid glands: primary hyperparathyroidism.

Authors:  B M BLACK
Journal:  Am J Surg       Date:  1958-03       Impact factor: 2.565

3.  Carcinoma of the parathyroid glands: 4 cases among 148 patients with hyperparathyroidism.

Authors:  O COPE; G L NARDI; B CASTLEMAN
Journal:  Ann Surg       Date:  1953-10       Impact factor: 12.969

4.  A CASE OF OSTEITIS FIBROSA CYSTICA (OSTEOMALACIA?) WITH EVIDENCE OF HYPERACTIVITY OF THE PARA-THYROID BODIES. METABOLIC STUDY I.

Authors:  R R Hannon; E Shorr; W S McClellan; E F Dubois
Journal:  J Clin Invest       Date:  1930-02       Impact factor: 14.808

5.  A CASE OF OSTEITIS FIBROSA CYSTICA (OSTEOMALACIA?) WITH EVIDENCE OF HYPERACTIVITY OF THE PARA-THYROID BODIES. METABOLIC STUDY II.

Authors:  W Bauer; F Albright; J C Aub
Journal:  J Clin Invest       Date:  1930-02       Impact factor: 14.808

6.  SURGERY OF HYPERPARATHYROIDISM: THE OCCURRENCE OF PARATHYROIDS IN THE ANTERIOR MEDIASTINUM AND THE DIVISION OF THE OPERATION INTO TWO STAGES.

Authors:  O Cope
Journal:  Ann Surg       Date:  1941-10       Impact factor: 12.969

7.  The surgical treatment of hyperparathyroidism, with a report of 27 cases.

Authors:  W F RIENHOFF
Journal:  Ann Surg       Date:  1950-06       Impact factor: 12.969

8.  Metastasizing Carcinoma of the Parathyroid Gland with Osteitis Fibrosa Cystica and Extensive Calcinosis.

Authors:  J T Ellis; D P Barr
Journal:  Am J Pathol       Date:  1951-06       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.